23andMe (MEHCQ) Stock Price, News & Analysis

Company Overview

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.

Key Stats

• Today's Range: $3.91 to $3.95
• 50-Day Range: N/A
• 52-Week Range: $0.47 to $7.88
• Volume: 23,490 shs
• Average Volume: 1.83 million shs
• Market Capitalization: $108.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MEHCQ Stock Analysis - Frequently Asked Questions

How have MEHCQ shares performed this year?

23andMe's stock was trading at $4.00 at the start of the year. Since then, MEHCQ shares have increased by 0.0% and is now trading at $4.00.

How do I buy shares of 23andMe?

Shares of MEHCQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/11/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MEHCQ
• CIK: 1804591
• Web: www.23andme.com
• Phone: 650-938-6300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$280.89 million
• Net Margins: -130.25%
• Pretax Margin: -116.70%
• Return on Equity: -827.24%
• Return on Assets: -87.31%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.81
• Quick Ratio: 0.69

Sales & Book Value

• Annual Sales: $189.90 million
• Price / Sales: 0.58
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.97) per share
• Price / Book: -4.12

Miscellaneous

• Outstanding Shares: 27,540,000
• Free Float: 20,292,000
• Market Cap: $110.16 million
• Optionable: N/A
• Beta: 2.14